O -(2- 18 F-fluoroethyl)- l -tyrosine ( 18 F-FET) uptake in insulinoma: first results from a xenograft mouse model and from human - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Nuclear Medicine and Biology Année : 2017

O -(2- 18 F-fluoroethyl)- l -tyrosine ( 18 F-FET) uptake in insulinoma: first results from a xenograft mouse model and from human

Résumé

Introduction: Herein we have evaluated the uptake of O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) in insulinoma in comparison with those of 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-FDOPA) providing first data from both murine xenograft model and one patient with proved endogenous hyperinsulinemic hypoglycemia. Methods: Dynamic 18F-FET and carbidopa-assisted 18F-FDOPA PET were performed on tumor-bearing nude mice after subcutaneous injection of RIN-m5Fmurine beta cells and on a 30-year-oldmanwith type-1 multiple endocrine neoplasia and hyperinsulinemic hypoglycemia defined by a positive fasting test. Results: Seven and three nude mice bearing a RIN-m5F insulinoma xenograft were respectively studied by 18FFET and 18F-FDOPA μPET. Insulinoma xenograftwas detected in all the imaged animals. Xenograftwas characterized by an early but moderate increase of 18F-FET uptake followed by a slight decline of uptake intensity during the 20 min dynamic acquisition. Tumoral radiotracer peak intensity and the highest tumor-to-background contrast were reached about 5 minutes after 18F-FET iv. injection (mean SUV: 1.21 ± 0.10). The biodistribution of 18F-FET and 18F-FDOPA and their dynamic tumoral uptake profile and intensitywere similar. In the examined patient, 18F-FDOPA and 18F-FET PET/CT showed one concordant focal area of well-defined increased uptake in the pancreatic tail corresponding to 11 mm histologically proved insulinoma. The SUVmax tumor to liver ratio was 1.5, 1.1 for 18F-FDOPA, 1.1, 1 for 18F-FET at early (0-5 min post injection) and delayed (5-20 min post injection) PET/CT acquisition, respectively. Despite the relatively low tumoral uptake intensity, insulinoma was clearly identified due to the low background in the pancreas. At the contrary, no 18F-FDOPA or 18F-FET tumoral uptake was revealed on whole-body PET/CT images performed about 30 min after radiotracer administration. Note of worth, the dynamic uptake pattern of 18F-FET and 18F-FDOPA were similar between human insulinoma and mice xenograft tumor. Conclusion: 18F-FET PET compared equally to 18F-FDOPA PET in a preclinical RIN-m5F murine model of insulinoma and in one patient with insulinoma-related hypoglycemia. However, in both cases, the tumoral uptake intensity was moderate and the tumor was only visible until 20 min after radiotracer injection. Hence, caution should be taken before asserting the translational relevance of our results in the clinical practices. However, the structural analogies between 18F-FET and 18F-FDOPA as well as the limited pancreatic uptake of 18F-FET in human, encourage evaluating 18F-FET as diagnostic radiotracer for insulinoma detection in further prospective studies involving large cohorts of patients.
Fichier non déposé

Dates et versions

hal-01645692 , version 1 (23-11-2017)

Identifiants

Citer

Alessio Imperiale, Frédéric Boisson, Guillaume Kreutter, Bernard Goichot, Izzie Jacques Namer, et al.. O -(2- 18 F-fluoroethyl)- l -tyrosine ( 18 F-FET) uptake in insulinoma: first results from a xenograft mouse model and from human. Nuclear Medicine and Biology, 2017, 53, pp.21 - 28. ⟨10.1016/j.nucmedbio.2017.07.005⟩. ⟨hal-01645692⟩
74 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More